Run by Russian executives, FDS Pharma owns patents to vaccines and produces active pharmaceutical ingredients (APIs) for the Russian and other markets, according to globes.co.il.
Singapore-based SciGen, a subsidiary of Bioton is a fully integrated biotechnology company developing, manufacturing, and marketing biopharmaceuticals.
SciGen has set up the SciGen Israel plant for $10m, because of the financial difficulties, SciGen has divested SciGen Israel and its vaccine production and marketing rights.